Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Aug 5 2018

Chronic Alcohol Abuse

Snapshot
  • A 56-year-old man is brought to the ED after he had a severe episode of hematemesis. On exam, you note spider angiomas, and abdominal ascites. His hand is show at right.  

Introduction
  • Definition is clinical
    • CAGE questions (need 2 positive)
      • Cut - Do you ever feel you should cut back on drinking?
      • Annoyed - Do you ever feel annoyed when other question your drinking?
      • Guilty - Do you ever feel guilty for your drinking?
      • Eye-opener - Do you never need an eye-opener in the morning?
Presentation
  • Symptoms 
    • due to liver failure
      • altered mental status/encephalopathy
        • due to reduced excretion of ammonia
        • worse in alkalemic states
          • NH3 favored over NH4+
            • lactulose acidifies gut contents and leads to increased NH4+ loss in the stool
      • bleeding
        • due to reduced synthesis of coagulation factors
  • Physical exam
    • neurological findings
      • cerebellar dysfunction (gait instability, truncal ataxia, dysdiadochokinesia, intention tremor and hypotonia)
         
    • findings from liver failure 
      • asterixis 
      • jaundice 
        • reduced excretion of billirubin
      • pitting ankle edema 
        • reduced synthesis of albumin
    • findings from hyperestrinism
      • palmar erythema 
      • gynecomastia 
      • spider angiomas 
      • female hair distribution
    • findings from portal hypertension
      • hepatosplenomegaly
      • caput medusae 
      • ascites 
Evaluation
  • CAGE test
    • tried to Cut down, been Annoyed, felt Guilty, and had an Eye-opener
    • 2 or more yes answers is considered positive test
  • Serology
    • transaminitis
      • AST:ALT > 2:1
    • serum γ-glutamyltransferase (GGT) is most specific for recent use
    • MCV will be elevated in chronic users
Treatment
  • Pharmacologic
    • disulfiram
      • aversive conditioning: blocks acetaldehyde dehydrongenase leading to build up of unpleasant intermediate metabolite when ETOH is consumed
    • acamprosate (low/medium evidence)
      • relapse prevention by blocking glutamate receptor
    • naltrexone
      • reduces cravings (opioid antagonist)
    • gabapentin
    • topiramate
  • Psychotherapy
    • Alcoholics Anonymous (AA) and other peer support groups - seem to be the most effective by some sources
    • motivational interviewing to encourage entrance into AA
    • rehabilitation
Prognosis, Prevention, Complications
  • Complications 
    • alcoholic hepatitis/cirrhosis
    • esophageal varices 
    • pancreatitis
      • chronic pancreatitis will present with weight loss, vitamin ADEK deficiency, low/normal amylase and lipase 
    • peripheral neuropathy
    • testicular atrophy
    • increased cancer risk
      • oral, laryngeal, pharyngeal, esophageal, lung, and liver
      • squamous cell carcinoma is classically associated
ED Management
Inpatient Management
Chronic Management
  • Prevent further ethanol intake
  • Prevent individual from harming self or others
  • Sedate patient if agitated or aggressive
  • Order urine toxicity screen
  • Stabilize vitals if necessary
  • Administer (in order)
    • thiamine and Mg2+
    • multivitamin
    •  B12/folate
    • IV fluids + dextrose
  • Begin CIWA and benzodiazepine taper if signs of withdrawal
  • Do not administer medications that lower seizure threshhold (bupropion, haloperidol)
  • Begin psychotherapy (must occur with medications)
    • individual
    • group (AAA)
  • Begin medication immediately
    • disulfiram
    • naltrexone
    • acamprosate
    • gabapentin
    • topiramate

Question
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options